MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
LCTX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Lineage Cell Therapeutics (LCTX) Ownership - Who owns Lineage Cell Therapeutics?

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
2173 Salk Avenue
Phone
+1 442 287-8990
Employees
77
Web
https://www.lineagecell.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
306.64M
P/E Ratio
N/A
Total Cash
53.38M
Projected Growth
N/A
Total Debt
2.39M
Revenue
14.78M
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash/Share
0.21
Total Debt/Equity
N/A
Revenue/Share
0.06 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
LCTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for LCTX
A.I. Advisor
published General Information

General Information

a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, and neurological conditions

Industry Biotechnology

Profile
Details
Industry
N/A
Address
2173 Salk Avenue
Phone
+1 442 287-8990
Employees
77
Web
https://www.lineagecell.com